To better understand the relationship between clinicopathological characteristics of ccRCC patients and TGF-β pathway genes, we systematically analyzed the correlation between risk scores based on five TGF-β pathway genes and clinicopathological characteristics of ccRCC patients. This evidence concerns the gene TGFB1 and nonpapillary renal cell carcinoma.